VISIOPHARM A/S
CVR 26186676 · Public limited company (A/S) · Active · Low risk
VISIOPHARM A/S is a Public limited company (A/S), founded on , based in Hørsholm. The company is registered in the industry computerkonsulentbistand og forvaltning af computerfaciliteter. Our model estimates a bankruptcy risk of 0.6% over the next 12 months, which is 0.4 times the average for Danish companies. 20 annual reports have been published. CEO: Michael Grunkin, Johan Doré Hansen.
Bankruptcy risk for VISIOPHARM A/S
0.4 × the average (1.41%) · higher risk than 66% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 26186676
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (25 years)
- Address
- Agern Alle 24, 2.
2970 Hørsholm - Municipality
- Rudersdal
- Industry
- Computerkonsulentbistand og forvaltning af computerfaciliteter (622000)
Bankruptcies in the industry: Konsulentbistand vedrørende informationsteknologi - Share capital
- DKK 1.7m
- Employees
- 48 (2018)
- Auditor
- Beierholm Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 24 |
| Missing annual report | No |
| Negative equity | – |
| Equity ratio | – |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 3 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 74 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 |
|---|
Latest annual report: Reporting class C, medium-size enterprise · auditor's statement: Auditor's report on audited financial statements · Beierholm GodkendtRevisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Oct 2024 – 30 Sep 2025 | 80 | ||
| 1 Oct 2023 – 30 Sep 2024 | 81 | ||
| 1 Oct 2022 – 30 Sep 2023 | 76 | ||
| 1 Oct 2021 – 30 Sep 2022 | 98 | ||
| 1 Oct 2020 – 30 Sep 2021 | 82 | ||
| 1 Oct 2019 – 30 Sep 2020 | 78 | ||
| 1 Oct 2018 – 30 Sep 2019 | 99 | ||
| 1 Oct 2017 – 30 Sep 2018 | 108 | ||
| 1 Oct 2016 – 30 Sep 2017 | 152 | ||
| 1 Oct 2015 – 30 Sep 2016 | 98 | ||
| 1 Oct 2014 – 30 Sep 2015 | 152 | ||
| 1 Oct 2013 – 30 Sep 2014 | 153 | ||
| 1 Oct 2012 – 30 Sep 2013 | 161 | ||
| 1 Oct 2011 – 30 Sep 2012 | 96 | ||
| 1 Oct 2010 – 30 Sep 2011 | 109 | ||
| 1 Oct 2009 – 30 Sep 2010 | 137 | ||
| 1 Oct 2008 – 30 Sep 2009 | 153 | ||
| 1 Oct 2007 – 30 Sep 2008 | 126 | ||
| 1 Oct 2006 – 30 Sep 2007 | 151 | ||
| 1 Oct 2005 – 30 Sep 2006 | 162 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Michael Grunkin | Current | |
| CEO | Johan Doré Hansen | Current | |
| CEO | Niels Tækker Foged | ||
| Board | Per Fredrik Thorell | Current | |
| Board | Evis Hursever | Current | |
| Board | Andrew James Thomson | Current | |
| Board | Michael Grunkin | ||
| Board | Steen Bundgaard Lauritzen | ||
| Board | Jens Harpøth Zilstorff | ||
| Board | Anders Weber | ||
| Board | Michael Grunkin | ||
| Board | Susanne Høiberg | ||
| Board | Martin Bonde | ||
| Board | Thomas Weilby Knudsen | ||
| Board | Niels Tækker Foged | ||
| Board | Johan Doré Hansen | ||
| Board | Henrik Stender | ||
| Board | Susanne Høiberg | ||
| Board | Patrik Olof Dahlén | ||
| Board | Per Arne Rickard Lindelöf | ||
| Board | Martin Bonde | ||
| Board | Claus Henrik Berner Møller | ||
| Board | Jeannett Hvidkjær | ||
| Board | Morten Frost Norgreen | ||
| Owner (100%) | Neptune Denmark Holdco ApS | Current | |
| Owner (50%) | VISIOPHARM HOLDING ApS | ||
| Owner (5%) | Niels Tækker Foged | ||
| Owner (5%) | IVS A/S | ||
| Owner (10%) | IVS FUND II K/S | ||
| Owner (15%) | Mikroinstrument i Skåne AB | ||
| Owner (15%) | Arbejdsmarkedets Tillægspension | ||
| Owner (5%) | VÆKSTFONDEN | ||
| Owner (25%) | VISIOPHARM HOLDING ApS | ||
| Owner (5%) | C.L. DAVIDS FOND OG SAMLING | ||
| Owner (5%) | Mikroinstrument i Skåne AB | ||
| Owner (10%) | Johan Doré Holding ApS | ||
| Owner (10%) | Michael Grunkin Holding ApS | ||
| Owner (5%) | Danmarks Eksport- og Investeringsfond | ||
| Auditor | Beierholm Godkendt Revisionspartnerselskab | Current | |
| Auditor | BEIERHOLM, STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | Beierholm Godkendt Revisionspartnerselskab | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | Michael Grunkin | Current |
The CEOs' other companies
Michael Grunkin – 4 other companies
- CARECORD ApS Opløst
- Michael Grunkin Holding ApS Active
- OSTEOMATE ApS Opløst
- VISIOPHARM HOLDING ApS Fusioneret
Johan Doré Hansen – 2 other companies
- Johan Doré Holding ApS Active
- OSTEOMATE ApS Opløst
Niels Tækker Foged – 6 other companies
- AKTIESELSKABET 'MOLTKESVEJSHAVE VIII' Active
- BIONANOPHOTONICS A/S Opløst
- BIOPORTO A/S Active
- IN SITU RCP A/S Opløst
- NORDIC BIOSCIENCE CLINICAL STUDIES A/S Opløst
- Solsten Diagnostics International ApS Active
Address history (5 moves)
| Agern Alle 24, 2., 2970 Hørsholm | |
| Agern Alle 3, 2970 Hørsholm | |
| Bøge Alle 5, 2970 Hørsholm | |
| Bøge Alle 5, 2970 Hørsholm | |
| c/o Danmarks Tekniske Universitet, Akademivej 451, 2800 Kgs.Lyngby | |
| Skodsborgvej 408, 2942 Skodsborg |
Former names
| VISIOPHARM A/S | – now |
| VISIOPHARM ApS | – |
Employees per year
Other companies at the same address
- AVS 07.02.2022 ApS Bankrupt
- Agger Electronic Holding ApS Bankrupt
- Agmondo ApS Bankrupt
- Datoselskabet af 29. august 2024 ApS Bankrupt
- Dinnr ApS Bankrupt
- Euronome Analyzer ApS Bankrupt
- ID2ME A/S Bankrupt
- Kube8 ApS Bankrupt
- SAFESONE HOLDING A/S Bankrupt
- Safesone ApS Bankrupt
- UDVIKLINGSSELSKABET OP2013 ApS Bankrupt
- ACRONORDIC ApS Active
- ALO Patents ApS Active
- ALTOO ApS Active
- Alsted Innovation ApS Active
- Asergo ApS Active
- Asergo Holding ApS Active
- Breye Therapeutics ApS Active
- CLARA INVEST ApS Active
- COLDING CONSULT ApS Active
- CPC - CENTER FOR PRODUCT CUSTOMIZATION ApS Active
- CROXX MED ApS Active
- Central Park Boathouse ApS Active
- Convenience Group ApS Fusioneret
- DALL ENERGY ApS Active
Similar companies in Rudersdal
- Konfide ApS Birkerød
- HYdigital ApS Vedbæk
- Antaras Nordic ApS Vedbæk
- DPO Agent ApS Vedbæk
- R1SK ApS Holte
- Schönbeck ApS Holte
- umage.ai ApS Virum
- Novatilia ApS Holte
- Kjærbo Defence ApS Birkerød
- RoqiAi ApS Nærum
- cloudfluence ApS Nærum
- IPH ApS Holte
Questions and answers about VISIOPHARM A/S
Has VISIOPHARM A/S gone bankrupt?
No, VISIOPHARM A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of VISIOPHARM A/S?
Our model estimates a bankruptcy risk of 0.6% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the CEO of VISIOPHARM A/S?
Michael Grunkin, Johan Doré Hansen are the CEOs of VISIOPHARM A/S.
Who is the auditor of VISIOPHARM A/S?
VISIOPHARM A/S most recently used Beierholm Godkendt Revisionspartnerselskab.
When was VISIOPHARM A/S founded?
VISIOPHARM A/S was founded on 9 July 2001.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.